van Eijk, Ruben P A <br/><br/>
Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials.  [electronic resource] 

 -  Journal of neurology, neurosurgery, and psychiatry  12 2019 
 - 1331-1337 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-330X 
<br/><br/><label>Standard No.: </label>10.1136/jnnp-2019-320998  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amyotrophic Lateral Sclerosis--drug therapy<br/>Clinical Trials as Topic--methods<br/>Endpoint Determination--methods<br/>Female<br/>Humans<br/>Male<br/>Quality of Life<br/>Research Design<br/>Riluzole--therapeutic use